Skip to main content

Table 8 Significantly higher expressed genes in CD56+ compared to CD56 SMDC

From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence

Gene CD56+ SMDC CD56 SMDC Log2 fold change
KBTBD10 10.64 3.61 7.11
CHRNA1 12.42 6.64 5.77
TTN 10.81 5.37 5.63
ALDH1A1 10.84 5.24 5.52
COL14A1 10.71 5.69 5.36
CASQ2 9.09 4.60 5.29
F13A1 10.54 5.44 5.24
NEB 10.06 5.21 5.02
MEGF10 10.83 5.99 4.85
PDLIM3 10.95 6.13 4.85
STAC3 10.06 5.27 4.78
OLFML2A 11.19 6.53 4.77
MYL1 10.48 6.30 4.76
NCAM1 10.03 5.42 4.75
DES 10.92 6.13 4.75
KCNN3 9.95 5.56 4.57
SMYD1 8.52 4.66 4.51
CHRNG 10.18 5.84 4.46
TRIM55 8.94 4.68 4.42
TMEM8C 9.92 6.10 4.30
LRRN1 9.18 5.47 4.03
DLL1 9.63 5.84 4.01
ACTA1 10.01 6.46 4.00
ITGB6 8.37 4.54 3.99
METTL7B 10.01 6.02 3.99
ITGA8 8.86 4.87 3.99
ASB5 8.45 4.60 3.97
MYOG 10.27 6.58 3.93
FABP3 9.68 5.94 3.92
PRUNE2 9.31 5.47 3.84
CHST15 10.93 7.11 3.82
TNNT1 9.61 5.92 3.82
SGCA 10.66 6.93 3.75
ITGA7 10.14 6.38 3.75
RUNX1IT1 8.98 5.23 3.75
MYBPH 9.77 6.08 3.74
FAM49A 10.19 6.56 3.68
GABRB2 8.38 5.04 3.67
CDON 9.53 5.89 3.66
NRCAM 7.74 4.73 3.58
TPPP3 10.23 6.67 3.57
RCAN2 10.26 6.71 3.55
MUSK 8.33 4.86 3.54
L1CAM 9.04 5.49 3.54
MYF5 8.51 5.37 3.54
MYOD1 9.83 6.30 3.53
TTC9 9.81 6.29 3.53
VCAM1 8.40 4.98 3.49
CHRNB1 9.92 6.58 3.47
DCLK1 9.38 6.08 3.43
DYSF 8.96 5.74 3.41
HSPB3 7.91 4.89 3.39
RAPSN 10.17 6.86 3.36
MURC 8.90 5.62 3.31
GPRC5B 8.99 6.07 3.29
SYNPO2L 8.65 5.54 3.28
KIAA1244 9.30 6.37 3.26
ALPK3 8.99 5.75 3.25
ACTN2 8.02 5.20 3.20
PCDH7 8.78 5.60 3.19
MYLPF 10.04 7.05 3.19
LMOD3 7.26 4.50 3.15
CDH15 9.30 6.20 3.09
EYA1 7.72 4.73 3.08
FGFR4 8.45 5.57 3.03
TXLNB 7.97 5.03 3.01
PCDHB14 9.59 6.62 2.99
NEDD4L 9.32 6.34 2.99
MIR27B 8.05 5.10 2.98
GATM 8.19 5.35 2.98
PALMD 9.78 6.82 2.97
MEF2C 7.89 5.04 2.96
DAPK1 7.81 5.00 2.96
A2M 8.91 6.08 2.91
ZIC1 7.66 4.76 2.89
SCN5A 8.40 5.51 2.89
ANKRD29 9.15 6.40 2.82
ZNF608 8.34 5.54 2.81
SAMD5 8.39 5.67 2.81
SLC12A7 9.24 6.70 2.78
PCDHB5 8.62 5.86 2.78
IGFBPL1 8.41 5.77 2.77
NPNT 7.33 4.86 2.75
RGS16 9.28 6.63 2.72
DES 9.48 6.79 2.70
GMPR 8.65 6.02 2.70
IL17RD 8.91 6.25 2.69
F11R 8.57 5.92 2.65
MYPN 8.53 5.99 2.64
FMNL1 8.89 6.35 2.57
ST8SIA5 7.90 5.37 2.57
LAMA3 8.37 5.83 2.57
C1orf187 8.49 5.97 2.57
TSPAN15 8.08 5.50 2.56
PAX7 8.37 6.03 2.51
DBHAS1 8.10 5.60 2.50
FGL2 8.77 6.32 2.50
DMBT1 7.80 5.28 2.48
JUP 9.49 7.01 2.46
JAM2 8.36 5.93 2.45
PNPLA3 8.42 5.94 2.45
TNS3 8.92 6.53 2.39
CLSTN2 8.88 6.48 2.38
PCDH19 8.75 6.49 2.37
FGF11 8.92 6.59 2.36
VAMP8 8.40 6.07 2.33
ST8SIA2 8.05 5.75 2.31
PCDHB15 7.46 5.16 2.30
TUBA3FP 8.18 5.88 2.30
LAMA5 9.24 7.01 2.27
SYTL2 8.87 6.64 2.24
ECM2 8.33 6.08 2.24
ITPR1 8.37 6.17 2.24
GAS1 9.46 7.28 2.18
HOXA2 8.02 5.88 2.18
PM20D2 7.87 5.76 2.11
SPRY1 7.45 5.42 2.07
PKNOX2 8.21 6.17 2.07
WNT9A 8.93 6.87 2.07
TRIM72 8.61 6.60 2.05
SIX1 7.69 5.64 2.05
SLC40A1 7.89 5.89 2.03
PCDHB12 7.42 5.40 2.02
GPR153 9.30 7.31 2.02
PCDHB16 7.33 5.37 1.96
PCDHB3 7.64 5.70 1.93
PCDHB9//PCDHB10 8.25 6.35 1.89
TOX 9.11 7.23 1.88
CFI 7.39 5.53 1.86
HEYL 7.95 6.14 1.86
BOC 8.98 7.15 1.84
TMEM150C 7.91 6.07 1.83
WBSCR17 7.41 5.65 1.79
SHISA2 7.69 5.90 1.78
PAX3 7.49 5.73 1.77
PPFIA4 8.49 6.72 1.77
AR 8.06 6.30 1.76
SERPING1 8.21 6.47 1.76
TSPAN9 8.23 6.49 1.73
BMP4 7.29 5.58 1.72
MTSS1 8.25 6.60 1.67
DTNA 7.48 5.83 1.66
TMEM86A 7.40 5.78 1.63
DUSP13 8.04 6.43 1.62
C1orf38 8.01 6.44 1.57
KY 8.38 6.83 1.56
LAPTM5 8.50 6.97 1.53
SYTL3 8.34 6.86 1.48
PCDHB2 7.55 6.10 1.45
KIAA1549 8.70 7.27 1.44